# Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/oversight-of-clinical-investigations-a-risk-based-approach-to-monitoring-guidance-for-industry/ad5abb22-0ad2-4152-a7b3-c9de659f6843

> FDA guidance document: Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring:  Guidance for Industry. Issue date: August 07, 2013. Get complete insights and analysis.

---

## Details

- Title: Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2013-08-07
- Last Changed: 2024-11-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0597">FDA-2011-D-0597</a>

## Related Documents

- [Expedited Programs for Serious Conditions | Drugs and Biologics](https://www.globalkeysolutions.net/guidances/guidance-document/expedited-programs-for-serious-conditions-drugs-and-biologics/d49c172d-43db-4e76-a0fd-1f51de9ecff3)
- [Dear Health Care Provider Letters: Improving Communication of Important Safety Information](https://www.globalkeysolutions.net/guidances/guidance-document/dear-health-care-provider-letters-improving-communication-of-important-safety-information/a3ea6356-848d-4286-86e9-8ac6013377e1)
- [CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports](https://www.globalkeysolutions.net/guidances/guidance-document/cmc-postapproval-manufacturing-changes-to-be-documented-in-annual-reports/67341cfe-8a48-4fc7-9817-6f9ed89768cf)